- Home
- ADCT vs MERC Comparison
ADCT vs MERC Comparison
Compare ADCT & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- MERC
- Stock Information
- Founded
- ADCT 2011
- MERC 1968
- Country
- ADCT Switzerland
- MERC Canada
- Employees
- ADCT N/A
- MERC N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- MERC Paper
- Sector
- ADCT Health Care
- MERC Basic Materials
- Exchange
- ADCT Nasdaq
- MERC Nasdaq
- Market Cap
- ADCT 241.0M
- MERC 271.5M
- IPO Year
- ADCT 2020
- MERC 1987
- Fundamental
- Price
- ADCT $3.17
- MERC $3.89
- Analyst Decision
- ADCT Strong Buy
- MERC Hold
- Analyst Count
- ADCT 6
- MERC 3
- Target Price
- ADCT $7.80
- MERC $5.33
- AVG Volume (30 Days)
- ADCT 913.9K
- MERC 434.8K
- Earning Date
- ADCT 08-05-2025
- MERC 07-31-2025
- Dividend Yield
- ADCT N/A
- MERC 7.75%
- EPS Growth
- ADCT N/A
- MERC N/A
- EPS
- ADCT N/A
- MERC N/A
- Revenue
- ADCT $75,817,000.00
- MERC $1,996,904,000.00
- Revenue This Year
- ADCT $11.75
- MERC $2.43
- Revenue Next Year
- ADCT $10.29
- MERC $6.12
- P/E Ratio
- ADCT N/A
- MERC N/A
- Revenue Growth
- ADCT 10.49
- MERC N/A
- 52 Week Low
- ADCT $1.05
- MERC $3.20
- 52 Week High
- ADCT $4.13
- MERC $8.57
- Technical
- Relative Strength Index (RSI)
- ADCT 59.73
- MERC 58.53
- Support Level
- ADCT $2.66
- MERC $3.52
- Resistance Level
- ADCT $3.30
- MERC $4.04
- Average True Range (ATR)
- ADCT 0.20
- MERC 0.16
- MACD
- ADCT 0.01
- MERC 0.06
- Stochastic Oscillator
- ADCT 90.00
- MERC 76.92
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.